In the years of the COVID-19 pandemic, the effectiveness of government-ordered measures to contain the pandemic, such as regular testing and the wearing of medical masks, was repeatedly called into
"Infektiopod", a podcast in German language that has been providing information on human infectious diseases since 2019, is now being funded by the German Center for Infection Research (DZIF). The
On 1 June 2024, Professor Marcus Altfeld, Coordinator of the research area HIV at the German Center for Infection Research (DZIF), became Scientific Director of the Leibniz Institute of Virology (LIV)
HYpharm's innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against the bacterial pathogenStaphylococcus aureus including multi-resistant